Dangerous Drugs Board

What Dangerous Drugs Board does

The Dangerous Drugs Board (DDB) is the policy-making and coordinating body on drug abuse prevention and control in the Philippines, established under Republic Act 9165 (Comprehensive Dangerous Drugs Act of 2002) and operating under the Office of the President. The Board is composed of 17 members (3 Permanent, 12 Ex-Officio, 2 Regular) with the Chairman holding the rank of Secretary, and is supported by an 80-person Secretariat headquartered in Quezon City, Metro Manila. Its mandate spans policy formulation, preventive education, treatment and rehabilitation coordination, regulatory control of dangerous drugs and precursors, research and statistics, and international cooperation through ASEAN frameworks such as the ASOD Working Group on Research.

DDB's core digital products are the Online Application for Certification and Exemption Information System (OACEIS), an online portal for exemption certificate processing under RA 11032 (Ease of Doing Business Act), and the Treatment and Rehabilitation Admission Information System (TRAIS), which captures admissions data across 88 Drug Abuse Treatment and Rehabilitation Centers (76 residential, 12 outpatient). The agency also publishes the Philippine Anti-Illegal Drugs Strategy (PADS) as its national policy framework and uses a Geographic Information System (GIS) for spatial analysis. Behind these systems sits an ISO 9001:2015-certified Quality Management System held continuously since 2008.

DDB is funded entirely through annual national government appropriations under the General Appropriations Act and does not generate commercial revenue. Its "customer" base is institutional: partner government agencies (DOH, PDEA, DepEd, DOLE, DTI, TESDA, DSWD), 1,000+ Local Government Units via Anti-Drug Abuse Councils, the 88 DATRCs, and the Filipino public served through prevention education. E-payment for certificate fees is processed through Land Bank e-services. The agency's capital deployment in 2026 included ₱5.5M to DOH-TRC Bicutan and ₱5M to DOH-TRC Region II for facility improvements, distributed through coordinated programs rather than commercial transactions.

Name

Dangerous Drugs Board

Legal name

Dangerous Drugs Board

Website

https://ddb.gov.ph

Company type

Private

Operating status

Operating

Headcount range

51–100 employees

Short description

The Dangerous Drugs Board (DDB) is the Philippines' national policy-making and coordinating body on drug abuse prevention and control, operating under the Office of the President since 2002 under RA 9165. It coordinates policy, treatment, and prevention across 88 rehabilitation centers, partner government agencies, and 1,000+ local government units.

Ownership category

akta.pro rank

Product category

Government Regulatory Services - Drug Policy Administration

NAICS

Justice, Public Order, and Safety Activities (922), Regulation, Licensing, and Inspection of Miscellaneous Commercial Sectors (926150)

akta.pro primary industry

Controlled Substances & Narcotics Regulators (HLAJADAK)

akta.pro secondary industries

Controlled Substances & Pharmacy Regulation Authorities (HLAJACAI), Gambling, Alcohol & Controlled Substances Regulators (BPAIAOAN)

Keywords

• Drug policy regulation
• Treatment rehabilitation services
• Preventive education programs
• Controlled substances licensing
• Government drug control

Headquarters

HQ city

Quezon City

HQ country

Philippines

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Revenue model

1. Government Appropriations: The Dangerous Drugs Board operates as a government agency under the Office of the President of the Philippines, funded through annual national government appropriations as part of the General Appropriations Act. The Board does not generate commercial revenue but is allocated budgetary resources to carry out its mandate of drug abuse prevention and control.

Distribution channels5 records

Marketing channels9 records

Core offering

The Dangerous Drugs Board is the Philippine government's policy-making and coordinating body for drug abuse prevention and control, operating under the Office of the President. It develops and enforces national drug policies, issues Board Regulations and Resolutions, processes certificate applications via the OACEIS system, oversees 88 Drug Abuse Treatment and Rehabilitation Centers (DATRCs), and delivers preventive education programs including STEP and Life Skills Enhancement across government agencies, LGUs, and communities.

Product overview

The Dangerous Drugs Board (DDB) is the Philippine government's policy-making and regulatory body for drug abuse prevention and control. It does not offer a commercial product portfolio; rather, it provides government services including the Philippine Anti-Illegal Drugs Strategy (PADS) as the national policy framework, and the Online Application for Certification and Exemption Information System (OACEIS) for processing certificate applications. The Board's functions include preventive education programs, treatment and rehabilitation oversight, regulatory control, research and statistics, and issuance of board regulations and resolutions.

Differentiator

Problem solved

Functional benefit

Products and services

• Philippine Anti-Illegal Drugs Strategy (PADS)

Quantifiable outcome

• 88 DATRCs reporting to TRAIS system in 2024
• +2 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

13 partnerships are on record, tiered core and secondary.

• Department of Health (DOH)coreStrategic or Co-development PartnerThe DDB collaborates extensively with the Department of Health on treatment and rehabilitation services, operating 88 Drug Abuse Treatment and Rehabilitation Centers (DATRCs). DOH-TRC facilities receive financial assistance from DDB for facility improvements, and the agencies coordinate on recovery and reintegration support systems. The partnership encompasses the full continuum of care from prevention to treatment and aftercare.
• Philippine Drug Enforcement Agency (PDEA)coreStrategic or Co-development PartnerDDB and PDEA share office facilities (DDB-PDEA Building) and collaborate on regulatory matters including the OACEIS system for processing certifications. The agencies issue joint statements on controlled substances such as the unauthorized use of Nitrous Oxide (N2O). PDEA provides regional drug situation updates and law enforcement coordination for community-based anti-drug initiatives.
• Department of Education (DepEd)coreStrategic or Co-development PartnerDDB works with DepEd on integrating the National Drug Education Program within the Department's Learner Support Framework, and on school-based prevention education initiatives. The partnership includes collaborative efforts on preventive education in higher education through sustained engagement between government and academic institutions.
• Department of Labor and Employment (DOLE)secondaryStrategic or Co-development PartnerDDB collaborates with DOLE on workplace drug prevention policies and recovery support programs. DOLE participates in consultative meetings on recovery and reintegration support systems, contributing expertise on employment and livelihood programs for recovering individuals.
• Department of Trade and Industry (DTI)secondaryStrategic or Co-development PartnerDTI participates in consultative meetings on recovery and reintegration support systems, providing expertise on livelihood and trade-related programs for individuals recovering from substance use disorders.
• Technical Education and Skills Development Authority (TESDA)secondaryStrategic or Co-development PartnerTESDA participates in recovery and reintegration support initiatives, offering skills training and development programs that support the reintegration of recovering individuals into the workforce.
• Department of Social Welfare and Development (DSWD)secondaryStrategic or Co-development PartnerDSWD participates in consultative meetings on recovery and reintegration support systems, contributing social welfare programs and services for individuals and families affected by substance use.
• Local Government Units (LGUs)coreChannel Partner/ Reseller/ DistributorDDB partners with provincial, city, and municipal governments across the Philippines through their Anti-Drug Abuse Councils (ADACs, CADACs, BADACs). These partnerships enable local implementation of prevention programs, community-based rehabilitation, recovery support, and public engagement activities including IDADAIT observances.
• Provincial Government of CebusecondaryStrategic or Co-development PartnerDDB partnered with the Provincial Government of Cebu to conduct the Training of Trainers on Life Skills Enhancement in Drug Abuse Prevention Education in Cebu City as part of the IDADAIT 2026 national observance.
• ASEAN Senior Officials on Drug Matters (ASOD)coreStrategic or Co-development PartnerDDB participates in the ASOD Working Group on Research as part of ASEAN's technical platform for advancing scientific cooperation and evidence-based drug prevention and control. The Philippines showcased research initiatives at the 30th ASOD Working Group on Research in July 2026.
• Academic and Research InstitutionssecondaryStrategic or Co-development PartnerDDB collaborates with academic and research institutions for the DDB Saliksik National Research Conference and other evidence-generation initiatives. These partnerships strengthen the research foundation for drug abuse prevention and control policies.
• Treatment and Rehabilitation PractitionerssecondaryStrategic or Co-development PartnerDDB works with treatment and rehabilitation practitioners through consultative meetings and collaborative programs to strengthen the continuum of care from treatment through recovery and reintegration.
• Civil Society Organizations and Community PartnerssecondaryChannel Partner/ Reseller/ DistributorDDB engages civil society organizations and community partners in drug abuse prevention activities, public awareness campaigns, and community-based initiatives that extend the reach of government programs.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Regional players

• Agensi Anti Dadah Kebangsaan (AADK), Malaysia: Malaysia's national anti-drug agency under the Ministry of Home Affairs. AADK runs prevention, treatment, and rehabilitation programs analogous to DDB's mandate and is a fellow ASEAN member-state agency.
• Badan Narkotika Nasional (BNN), Indonesia: Indonesia's national narcotics agency coordinating prevention, eradication, and rehabilitation. BNN is a regional peer with parallel functions to DDB including community-based prevention and treatment program coordination.
• Central Narcotics Bureau (CNB), Singapore: Singapore's lead drug control agency. While more enforcement-focused, CNB is a comparable regional agency operating within the same ASEAN drug policy framework as DDB.
• Office of the Narcotics Control Board (ONCB), Thailand: Thailand's national drug policy and coordinating body under the Prime Minister's Office. ONCB mirrors DDB's mandate of integrating prevention, treatment, and supply-reduction policy at the national level within ASEAN.

Direct peers

• Philippine Drug Enforcement Agency (PDEA): Domestic peer sharing the DDB-PDEA Building and co-managing the OACEIS certification system. PDEA is the enforcement arm of the Philippine drug control regime, while DDB sets policy, making them tightly coupled counterpart agencies.

Broad incumbents

• United Nations Office on Drugs and Crime (UNODC): UN entity that sets global standards on drug prevention and control. UNODC's research and policy frameworks directly shape the work of national agencies like DDB through international cooperation frameworks.
• Drug Enforcement Administration (DEA), United States: U.S. federal drug control agency with both regulatory and enforcement authority. DEA is a broader incumbent that combines policy-setting and enforcement roles similar to the combined DDB/PDEA structure in the Philippines.

Emerging players

• National Institute on Drug Abuse (NIDA), United States: U.S. federal research agency advancing the science of drug abuse and addiction. NIDA parallels DDB's evidence-generation function, including the National Household Survey on drug abuse patterns and trends.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key highlights6 records

Customer concentration

• Xx.com/DDBgov
• YouTubeyoutube.com/@DDBgovph
• Facebookfacebook.com/DDBgov
• Instagraminstagram.com/ddbgov?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==
• LinkedInlinkedin.com/company/dangerous-drugs-board

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dangerous Drugs Board